百克生物(688276.SH)发预亏，预计2025年度归母净亏损2.2亿元到2.8亿元

Group 1 - The company expects a net profit loss attributable to shareholders of the parent company between 220 million to 280 million yuan for the year 2025, indicating a significant decline compared to the previous year [1] - The anticipated loss represents a decrease of 4.52 billion to 5.12 billion yuan year-on-year, reflecting a year-on-year reduction of 194.79% to 220.64% [1] - The company faces a challenging operating environment due to intensified industry competition, insufficient public vaccination willingness, and a declining birth rate [1]